The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2026

Filed:

Jul. 19, 2022
Applicant:

Emory University, Atlanta, GA (US);

Inventors:

Dennis C. Liotta, Atlanta, GA (US);

Edgars Jecs, Atlanta, GA (US);

Yesim Altas Tahirovic, Atlanta, GA (US);

Eric Miller, Atlanta, GA (US);

Lawrence Wilson, Atlanta, GA (US);

Assignee:

Emory University, Atlanta, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/14 (2006.01); A61K 31/4725 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/5383 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01); C07D 491/052 (2006.01); C07D 491/08 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61K 31/4725 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/5383 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 471/04 (2013.01); C07D 471/14 (2013.01); C07D 491/052 (2013.01); C07D 491/08 (2013.01); C07D 498/04 (2013.01);
Abstract

CXCR4 antagonists and pharmaceutical formulations thereof are disclosed. The compounds and pharmaceutical formulations disclosed herein can be used to antagonize the CXCR4 pathway for mobilizing stem cells or treating a condition, disorder, or disease associated with the CXCR4 pathway. Exemplary conditions, disorders, and diseases relevant to this disclosure include HIV infections, WHIM syndrome, Waldenström macroglobulinemia, chronic neutropenia, primary immune-deficiency, aplastic anemia, hypoplastic myelodysplastic syndrome, acute respiratory distress syndrome (ARDS), ankylosing spondylitis, autoimmune diseases, and cancers.


Find Patent Forward Citations

Loading…